Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Amyris (AMRS) News Today

Amyris logo
Amyris, Inc. (AMRS)
Amyris Receives Court Approval for Restructuring Plan
Amyris Inc AMRSQ
Gevo's Valentine's Day Massacre
Amyris, Inc. (AMRS) Soars: Stock Up 16.0%
Firm Retention Summary: Amyris
Why Amyris Stock Is Rocketing Higher
AMRS Stock Surges 152% as Amyris Files for Bankruptcy
Biotech firm Amyris files for bankruptcy in US
Amyris files for Chapter 11 bankruptcy
AMRS - Amyris, Inc.
Amyris, Inc. stock logo
SG Americas Securities LLC Buys 614,935 Shares of Amyris, Inc. (NASDAQ:AMRS)
SG Americas Securities LLC grew its holdings in Amyris, Inc. (NASDAQ:AMRS - Free Report) by 1,037.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 674,221 shares of the biotechnology company's stock after purchasi
Amyris, Inc. stock logo
Amyris, Inc. (NASDAQ:AMRS) Receives Consensus Rating of "Hold" from Analysts
Amyris, Inc. (NASDAQ:AMRS - Get Free Report) has been assigned an average recommendation of "Hold" from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and one has given a buy recommenda
John Melo Exits Amyris
Amyris Chief Executive John Melo Resigns
Amyris, Inc. stock logo
Amyris, Inc. (NASDAQ:AMRS) Short Interest Update
Amyris, Inc. (NASDAQ:AMRS - Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 65,520,000 shares, a growth of 14.0% from the May 15th total of 57,460,000 shares. Currently, 26.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,840,000 shares, the short-interest ratio is presently 13.5 days.
Amyris, Inc. stock logo
Insider Selling: Amyris, Inc. (NASDAQ:AMRS) CFO Sells 20,999 Shares of Stock
Amyris, Inc. (NASDAQ:AMRS - Get Rating) CFO Hermanus Kieftenbeld sold 20,999 shares of the firm's stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $0.95, for a total transaction of $19,949.05. Following the sale, the chief financial officer now owns 219,768 shares in the company, valued at approximately $208,779.60. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Get Amyris News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMRS and its competitors with MarketBeat's FREE daily newsletter.

The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

AMRS Media Mentions By Week

AMRS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AMRS
News Sentiment

0.00

0.48

Average
Basic Materials
News Sentiment

AMRS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AMRS Articles
This Week

0

0

AMRS Articles
Average Week

Get Amyris News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMRS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:AMRS) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners